Pre-TAVR Revascularization: Angiographic or Physiological?

In patients undergoing transcatheter aortic valve replacement (TAVR), fractional flow reserve (FFR) guided revascularization is associated with favorable results compared against the traditional angiography guided revascularization. 

Debemos tener en cuenta a la isquemia crítica de MM II en el TAVI

Given the complete lack of randomized studies, this observational study is the best we have to decide how to guide revascularization in patients with symptomatic severe aortic stenosis undergoing TAVR. 

The current trend clearly favors the conservative revascularization strategy that treats only proximal lesions as opposed to what we used to do some time ago, treating as many lesions as possible seeing as accessing the coronary arteries post implant might get harder. 

All patients with severe aortic stenosis and coronary artery disease by angiography were included in this retrospective analysis and were divided into two groups: angiography (122/216; 56.5%) vs FFR (94/216; 43.5%) guided TAVR. Patients were followed up at 2 years to assess major events rate. 


Read also: AHA 2019 | COMPLETE: Complete Revascularization Is Superior since It Treats Other Vulnerable Plaque.


Most of the lesions (78.2%) assessed with FFR resulted negative for ischemia according to the standard cutoff value of 0.80 and were therefore deferred.

The FFR guided group presented a higher event-free survival rate vs. the angiography group (92.6% versus 82.0%; HR, 0.4; CI 95%, 0.2–1.0; p=0.035).


Read also: AHA 2019 | Treat Stroke to Target: Post-Stroke Aggressive Therapy with Statins.


Patients whose lesions were deferred also presented a higher event-free survival rate than the angiography group (91.4% versus 68.1%; HR, 0.3; CI 95% 0.1–0.6; p=0.001), which is why it seems safe to defer lesions based on FFR in this understudied particular population.

Conclusion

FFR guided revascularization in patients with coronary lesions and severe aortic stenosis undergoing TAVR resulted favorable vs. angiography guided revascularization. 

Original Title: Physiological Versus Angiographic Guidance for Myocardial Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation.

Reference: Mattia Lunardi et al. J Am Heart Assoc. 2019; 8:e012618.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...